GlassScriptPhysician profile
Venkateswarlu Thota
NPI 1437111697
$23,312.52
in general payments reported to CMS, 2019-2025
43 companies · $3,130 in 2025
The $3,130 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,700 · 2020: $532 · 2021: $1,365 · 2022: $2,385 · 2023: $3,642 · 2024: $6,559 · 2025: $3,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,941 · Travel and Lodging: $4,370 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,940.98 |
| Travel and Lodging | $4,369.80 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,845.21 | 2019-2025 | Optis, Esprit, Aveir |
| Penumbra, INC. | $3,571.34 | 2023-2025 | Ruby Coil, Indigo System |
| E.R. Squibb & Sons, L.L.C. | $3,225.57 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $2,851.71 | 2019-2025 | |
| Abiomed | $1,666.05 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $779.05 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $726.23 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $617.22 | 2019-2024 | Farxiga |
| Endologix LLC | $603.32 | 2025 | Torus Stent Graft System, Endocross Device |
| Amgen INC. | $562.34 | 2019-2023 | Repatha |
| Inari Medical, INC. | $454.48 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $445.00 | 2019-2025 | Jardiance |
| Shockwave Medical, INC | $428.81 | 2020-2025 | |
| Edwards Lifesciences Corporation | $311.04 | 2020-2024 | Sapien 3 Ultra Resilia |
| Amarin Pharma, INC. | $274.20 | 2019-2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $261.17 | 2021-2025 | |
| Cvrx, INC. | $250.64 | 2024-2025 | Barostim Neo System |
| Philips North America LLC | $223.61 | 2022-2023 | |
| Bard Peripheral Vascular, INC. | $222.22 | 2021-2023 | Lutonix Drug Coated Balloon |
| Medtronic, INC. | $209.91 | 2022-2025 | Onyx Frontier, Endurant Iis |
| Stryker Corporation | $203.11 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Novo Nordisk INC | $187.50 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Silk Road Medical, INC. | $166.74 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Janssen Pharmaceuticals, INC | $152.34 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $128.50 | 2023-2024 | Inpefa |
| Heartflow, INC. | $126.29 | 2022 | |
| Siemens Medical Solutions USA, INC. | $103.65 | 2025 | Artis Icono Floor |
| Chiesi USA, INC. | $101.32 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.99 | 2020-2023 | Lifevest |
| Ge Healthcare | $89.67 | 2025 | |
| Boston Scientific Corporation | $69.49 | 2022-2025 | Comet |
| Surmodics, INC. | $63.77 | 2022-2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Pounce Thrombectomy |
| Cook Medical LLC | $51.35 | 2024 | Zilver Ptx |
| Cardiovascular Systems INC. | $46.97 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $40.01 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $30.90 | 2019 | |
| Gilead Sciences, INC. | $29.42 | 2019 | |
| Livanova USA, INC. | $21.77 | 2023 | Protekduo |
| Inspiremd LTD | $16.75 | 2025 | Cguard Prime Carotid Stent System |
| Esperion Therapeutics, INC. | $16.45 | 2020 | |
| Janssen Scientific Affairs, LLC | $13.42 | 2021 | |
| Elutia, INC. | $12.68 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venkateswarlu Thota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.